Does RIVASTIGMINE Cause Application site vesicles? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Application site vesicles have been filed in association with RIVASTIGMINE (Exelon). This represents 0.3% of all adverse event reports for RIVASTIGMINE.
24
Reports of Application site vesicles with RIVASTIGMINE
0.3%
of all RIVASTIGMINE reports
3
Deaths
7
Hospitalizations
How Dangerous Is Application site vesicles From RIVASTIGMINE?
Of the 24 reports, 3 (12.5%) resulted in death, 7 (29.2%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVASTIGMINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does RIVASTIGMINE Cause?
Death (1,229)
Fall (587)
Malaise (514)
Drug ineffective (510)
Product adhesion issue (478)
Vomiting (432)
Dementia alzheimer's type (428)
Memory impairment (385)
Nausea (383)
Pneumonia (378)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which RIVASTIGMINE Alternatives Have Lower Application site vesicles Risk?
RIVASTIGMINE vs RIVOTRIL
RIVASTIGMINE vs RIZATRIPTAN
RIVASTIGMINE vs ROACTEMRA
RIVASTIGMINE vs ROCURONIUM
RIVASTIGMINE vs ROFECOXIB